What is the atorvastatin (Lipitor) equivalent dose to pravastatin (Pravachol) 40 mg in terms of low-density lipoprotein (LDL) lowering efficacy?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: July 6, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

The equivalent dose of atorvastatin to pravastatin 40 mg for LDL-lowering efficacy is approximately 10 mg, as indicated by the most recent and highest quality study 1.

Key Points to Consider

  • Atorvastatin 10 mg daily will provide similar LDL cholesterol reduction as pravastatin 40 mg daily, with both medications typically lowering LDL by about 30-35% 1.
  • The difference in potency between these statins relates to atorvastatin's greater hepatic uptake, longer half-life, and more active metabolites compared to pravastatin, resulting in more efficient inhibition of HMG-CoA reductase, the key enzyme in cholesterol synthesis.
  • When transitioning between these medications, patients should have their lipid levels rechecked after 4-12 weeks to ensure the desired therapeutic effect is maintained.

Evidence Supporting the Recommendation

  • A 2019 study published in Circulation 1 provides the most recent and highest quality evidence, categorizing statin therapy into high-intensity, moderate-intensity, and low-intensity, with atorvastatin 10 mg considered a moderate-intensity statin, similar to pravastatin 40 mg.
  • The study also notes that individual responses to statin therapy can vary, and the estimated percent reductions in LDL-C are based on data across large populations 1.

Clinical Implications

  • Understanding the equivalent doses of different statins is crucial for maintaining consistent lipid-lowering effects when switching between medications.
  • Healthcare providers should consider the potency and efficacy of different statins, as well as individual patient responses, when making treatment decisions.
  • Regular monitoring of lipid levels is essential to ensure the desired therapeutic effect is maintained and to make any necessary adjustments to the treatment plan.

From the Research

Equivalent Dose of Atorvastatin to Pravastatin 40 mg

  • The equivalent dose of atorvastatin to pravastatin 40 mg in terms of low-density lipoprotein (LDL) lowering efficacy is not directly stated in the provided studies.
  • However, a study 2 compared the clinical outcomes of intensive lipid lowering with atorvastatin 80 mg/day and standard lowering with pravastatin 40 mg/day, and found that atorvastatin 80 mg/day caused a greater reduction in LDL-cholesterol than pravastatin 40 mg/day.
  • Another study 3 found that atorvastatin was significantly more effective than pravastatin in lowering LDL cholesterol, with atorvastatin 40 mg/day reducing LDL cholesterol by 57% compared to pravastatin 40 mg/day which reduced LDL cholesterol by 32% 4.
  • A study 5 found that atorvastatin 10 mg/day was more effective than pravastatin 40 mg/day in reducing LDL cholesterol, with a reduction of 38% compared to 32% for pravastatin 40 mg/day.
  • A study 6 found that atorvastatin 40 mg/day reduced LDL-C by 22.8%, while pravastatin 20 mg/day reduced LDL-C by 20.3%, and pravastatin 40 mg/day is not mentioned.

LDL Lowering Efficacy

  • The LDL lowering efficacy of atorvastatin and pravastatin can be compared based on the percentage reduction in LDL cholesterol.
  • Atorvastatin 40 mg/day has been shown to reduce LDL cholesterol by 57% 3, while pravastatin 40 mg/day has been shown to reduce LDL cholesterol by 32% 4.
  • Atorvastatin 10 mg/day has been shown to reduce LDL cholesterol by 38% 5, while pravastatin 20 mg/day has been shown to reduce LDL cholesterol by 20.3% 6.

Conclusion is not allowed, therefore, the response will be ended here.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.